Holen Sie sich die Stockscreener-App
36.69
7.91%
2.69
Handel nachbörslich:
36.69
Finanzdaten der Lb Pharmaceuticals Inc-Aktie (LBRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
143.92%
53.91
|
22.10 | 13.87 | 5.246 | - |
| Nonoperating Income/Loss |
24.20%
2.312
|
3.05 | 2.399 | 1.69 | - |
| Income/Loss From Continuing Operations Before Tax |
170.83%
-51.60
|
-19.05 | -11.47 | -3.556 | -4.87 |
| Income Tax Expense/Benefit |
-
|
- | 0.001 | - | - |
Net Income/Loss
|
170.83%
-51.60
|
-19.05 | -11.47 | -3.556 | -4.87 |
| Basic Average Shares |
6.71%
30.14
|
28.24 | - | 5.8069 | - |
| Diluted Average Shares |
6.71%
30.14
|
28.24 | - | 5.8069 | - |
| Basic Earnings Per Share |
155.22%
-1.71
|
-0.67 | - | -0.61 | - |
| Diluted Earnings Per Share |
155.22%
-1.71
|
-0.67 | - | -0.61 | - |
1.61%
2.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):